Literature DB >> 21415712

Severe prekallikrein deficiency due to a homozygous Trp499Stop nonsense mutation.

Takafumi Nakao1, Takahisa Yamane, Tomoko Katagami, Masayuki Shiota, Yasukatsu Izumi, Tomohiro Samori, Masayuki Hino, Hiroshi Iwao.   

Abstract

Prekallikrein deficiency is a rare autosomal recessive disease not considered to be associated with a tendency for bleeding, despite marked prolongation of activated partial thromboplastin time. Currently, six kinds of mutations in the prekallikrein gene are known to be associated with prekallikrein deficiency. In this report, we describe a patient with idiopathic thrombocytopenic purpura who was recognized to have severe prekallikrein deficiency. Molecular analysis of the patient's prekallikrein gene showed a homozygous Trp499Stop nonsense mutation that has not been reported previously. The mutant allele is predicted to encode a truncated protein lacking half of the catalytic domain of prekallikrein, suggesting that the truncated protein causes prekallikrein deficiency in the patient.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21415712     DOI: 10.1097/MBC.0b013e3283444ddb

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  4 in total

1.  A Rare Cause of Isolated Prolonged Activated Partial Thromboplastin Time: An Overview of Prekallikrein Deficiency and the Contact System.

Authors:  Ivy Riano; Klaorat Prasongdee
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec

Review 2.  The Effects of the Contact Activation System on Hemorrhage.

Authors:  Fabrício Simão; Edward P Feener
Journal:  Front Med (Lausanne)       Date:  2017-07-31

3.  Diagnostic Pearls and Clinical Implications of Prekallikrein Deficiency.

Authors:  Hassaan Yasin; Muhammad Omer Jamil; Lance A Williams Iii
Journal:  Cureus       Date:  2020-05-29

4.  Prekallikrein deficiency presenting as recurrent cerebrovascular accident: case report and review of the literature.

Authors:  Esteban Uribe Bojanini; Arturo Loaiza-Bonilla; Agustin Pimentel
Journal:  Case Rep Hematol       Date:  2012-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.